November 5, 2021

AFT appoints McPherson’s as Singapore distributor

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) has signed an exclusive distribution agreement with ASX-listed McPherson’s Limited (ASX: MCP) to drive the growth of its over-the-counter (OTC) products in Singapore.

The move aims to maximize the potential of AFT’s drugs in Singapore, where the OTC market is worth around $ 600 million and is expected to grow by around 5.45% to reach $ 800 million by 2026 *. It is also part of AFT’s broader strategy to strengthen its presence in Asia.

McPherson’s to distribute and market the tablet form of AFT’s patented pain relief drug Maxigesic, launched in Singapore in 2018, AFT’s premium liposomal nutritional supplements as well as a number of other newly registered pharmaceuticals. .

The agreement aims to leverage McPherson’s experienced sales and marketing teams in Singapore and will ensure that distribution strategies and product and merchandising activations are tailored to the local market.

AFT Pharmaceuticals Chief Executive Officer Dr Hartley Atkinson said: “This partnership confirms AFT’s commitment to create new categories and distribution in existing Asian markets and further expand the region.

“We are very pleased with the progress we have made in Singapore, but this agreement with McPherson’s, a specialist OTC distributor, ensures that we are aligned with the right partners to ensure success going forward.”

McPherson Chairman and CEO Grant Peck said, “We believe our established distribution channels and strong sales team in Singapore are a great fit for AFT and we are delighted what this partnership will achieve together. AFT’s OTC product brands have great synergies with McPherson’s focus on the health category and we are committed to driving market growth. ”

For and on behalf of AFT Pharmaceuticals Limited by Malcolm Tubby, Chief Financial Officer.

For more information:



Dr Hartley Atkinson

Richard Inder

General manager

The project

AFT Pharmaceutical

Phone. : +64 21 645 643

Phone. : +64 9488 0232

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand

Incorporated in New Zealand ARBN: ARBN 609 017 969 [email protected]

* https: //

About AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories across all major pharmaceutical distribution channels: over-the-counter (OTC), prescription and in a hospital environment. Our product portfolio includes both proprietary and licensed products, as well as patented, branded and generic drugs. Our business model is to develop and license products for sale by our own dedicated sales teams in our home markets of Australia and New Zealand and select markets in South East Asia, and to sublicense our products to local licensees and distributors in over 125 countries around the world. For more information about the company, visit our website

About McPherson’s Limited

McPherson’s, established in 1860, is a leading supplier of health, wellness and beauty products with operations in Australia, New Zealand and Asia. McPherson’s markets and distributes beauty care, hair care, skin care, vitamins, supplements and personal care items such as facial wipes, cottons and foot comfort products, as well than a range of kitchen essentials such as parchment paper, cling film and foil foil.

McPherson’s revenue comes primarily from its diverse portfolio of owned and market-leading brands including Dr. LeWinn’s, A’kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead and Maseur. McPherson’s also manages several brands for partner agencies.

For more information on McPherson’s business and strategy, and to view the most recent corporate video, please refer to the company’s website.

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand

Incorporated in New Zealand ARBN: ARBN 609 017 969 [email protected]


AFT Pharmaceuticals Limited published this content on 05 November 2021 and is solely responsible for the information it contains. Distributed by Public, unedited and unmodified, on 04 November 2021 07:55:05 PM UTC.

Leave a Reply

Your email address will not be published.